Eris Lifesciences up 9.5%

about 7 months ago
No Image

Eris Lifesciences is buzzing loud and clear today morning. Opening over 3.5% at Rs.732, the stock went on to hit an intraday high at Rs.773.40, up 9.5% on the back of an over 2-times surge in volumes.

The stock price surged after it announced that it has formed a joint venture (JV) with Mumbai-based MJ Biopharm to enter the insulin segment, marking Eris’s entry into the field of biopharma.

This JV, known as Eris MJ Biopharm, is a 70:30 venture with Eris holding a 70%, will market and distribute human and analogue insulin including Aspart, Glargine and Lispro and GLP-1 agonists and potentially other biopharma products in India. MJ will be responsible for the development, manufacturing and supply of these products to the JV.

Articles you may also like

Popular Comments

No comment posted for this article.